Growth Metrics

Elanco Animal Health (ELAN) Depreciation & Amortization (CF) (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Depreciation & Amortization (CF) for 9 consecutive years, with $174.0 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 6.1% to $174.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $680.0 million through Dec 2025, up 2.72% year-over-year, with the annual reading at $680.0 million for FY2025, 2.72% up from the prior year.
  • Depreciation & Amortization (CF) hit $174.0 million in Q4 2025 for Elanco Animal Health, down from $176.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $202.0 million in Q1 2021 to a low of $161.0 million in Q1 2025.
  • Historically, Depreciation & Amortization (CF) has averaged $171.7 million across 5 years, with a median of $170.5 million in 2021.
  • Biggest YoY gain for Depreciation & Amortization (CF) was 146.34% in 2021; the steepest drop was 21.62% in 2021.
  • Year by year, Depreciation & Amortization (CF) stood at $174.0 million in 2021, then fell by 3.45% to $168.0 million in 2022, then grew by 1.79% to $171.0 million in 2023, then decreased by 4.09% to $164.0 million in 2024, then increased by 6.1% to $174.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for ELAN at $174.0 million in Q4 2025, $176.0 million in Q3 2025, and $169.0 million in Q2 2025.